CDXC - ChromaDex Corporation

NasdaqCM - NasdaqCM Delayed price. Currency in USD
+0.41 (+7.54%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous close5.44
Bid0.00 x 0
Ask0.00 x 0
Day's range5.33 - 5.86
52-week range2.26 - 7.24
Avg. volume396,049
Market cap314.712M
PE ratio (TTM)N/A
EPS (TTM)-0.11
Earnings date14 Mar 2018 - 19 Mar 2018
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est7.50
Trade prices are not sourced from all markets
  • Globe Newswire14 days ago

    ChromaDex and Watsons Expand Partnership with TRU NIAGEN™ Retail Launch in Singapore

    ChromaDex Corp. (NASDAQ:CDXC), a fully integrated, science-based, nutraceutical company devoted to improving the way people age, announced the launch of TRU NIAGEN™ in Singapore with its retail partner, Watsons. Singapore is the second Asian market for the U.S. made dietary supplement, after Hong Kong. With over 6,000 stores in 11 Asian and European markets, Watsons is the leading health and beauty retailer in Asia and Europe.

  • Associated Press2 months ago

    ChromaDex posts 3Q profit

    The Irvine, California-based company said it had profit of 4 cents per share. Losses, adjusted to account for discontinued operations, were 7 cents per share. The natural products company posted revenue ...

  • We're sorry this is all we were able to find about this topic.

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes